Fabry Disease Research Highlights
| Overview / Abstract: |
This 30-minute CME-accredited program highlights the latest clinical research about Fabry disease, a rare X-linked lysosomal disorder that results in the cellular buildup of globotriaosylceramide. Characteristic features of Fabry disease include acroparesthesias, angiokeratomas, hypohidrosis, corneal opacity, gastrointestinal problems, tinnitus, and hearing loss. Fabry disease also involves potentially life-threatening complications such as progressive kidney damage, heart attack, and stroke. This CME program, hosted by Staci Kallish, DO, Associate Professor of Clinical Medicine at the University of Pennsylvania Health System Penn Medicine, provides an overview of the latest clinical research presented at WORLDSymposium 2023 focused on Fabry disease. |
|
Expiration |
Apr 30, 2024 |
|
Discipline(s) |
Nurse Practitioner , Physician CME, Physician Assistant CME |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
0.50 |
|
Accreditation |
American Academy of CME |
|
Presenters / Authors / Faculty |
Staci Kallish, DO |
|
Sponsors / Supporters / Grant Providers |
Amicus Therapeutics Inc and Chiesi USA |
|
Keywords / Search Terms |
CheckRare rare disease, rare disorder, lysosomal disorder, genetic disorder, Fabry, rare X-linked lysosomal disorder, globotriaosylceramide, acroparesthesias, angiokeratomas, hypohidrosis, corneal opacity, gastrointestinal problems, tinnitus, hearing loss. WorldSymposium, Free CE CME |
|